Literature DB >> 18042194

Gender and non-medical use of prescription opioids: results from a national US survey.

Jeanette M Tetrault1, Rani A Desai, William C Becker, David A Fiellin, John Concato, Lynn E Sullivan.   

Abstract

AIMS: Gender differences exist regarding alcohol and illicit drug use disorders in the United States. Little is known about the gender-related factors associated with non-medical use of prescription opioids.
DESIGN: Using data from the 2003 National Survey on Drug Use and Health, we examined risk factors for past-year non-medical use of prescription opioids stratified by gender.
SETTING: Non-institutionalized US residences. Participants Civilian, non-institutionalized US citizens aged 12 years and older. MEASUREMENTS: Self-reported alcohol and drug use, focusing specifically on past-year non-medical use of prescription opioids.
FINDINGS: Among 55 023 respondents, 4.8% reported past-year, non-medical use of prescription opioids. For both women and men, alcohol abuse/dependence and marijuana, hallucinogen, cocaine, non-medical stimulant and sedative/tranquilizer use were associated with past-year non-medical use of prescription opioids. Among women but not men, first use of illicit drugs beginning at 24 years or older [adjusted odds ratios (AOR) 1.90, 95% CI 1.05-3.44], serious mental illness (AOR 1.67, 95% CI 1.29-2.17) and cigarette smoking (AOR 1.33, 95% CI 1.05-1.68) were associated with past-year non-medical use of prescription opioids. Among men but not women, past-year inhalant use (AOR 1.93, 95% CI 1.28-2.92) was associated with the outcome.
CONCLUSIONS: For both women and men, illicit drug use is associated with the non-medical use of prescription opioids. Additionally, certain factors associated with the non-medical use of prescription opioids are notably gender-specific. Clinicians should recognize that patients with a history of illicit substance use or misuse of other prescription medications are at increased risk for non-medical use of prescription opioids, and that gender-specific factors can help to identify individuals at greatest risk.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18042194     DOI: 10.1111/j.1360-0443.2007.02056.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  74 in total

1.  Characteristics and correlates of men and women with prescription opioid dependence.

Authors:  Sudie E Back; Katie M Lawson; Lauren M Singleton; Kathleen T Brady
Journal:  Addict Behav       Date:  2011-03-25       Impact factor: 3.913

2.  Age and gender trends in long-term opioid analgesic use for noncancer pain.

Authors:  Cynthia I Campbell; Constance Weisner; Linda Leresche; G Thomas Ray; Kathleen Saunders; Mark D Sullivan; Caleb J Banta-Green; Joseph O Merrill; Michael J Silverberg; Denise Boudreau; Derek D Satre; Michael Von Korff
Journal:  Am J Public Health       Date:  2010-08-19       Impact factor: 9.308

3.  Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III.

Authors:  Bradley T Kerridge; Tulshi D Saha; S Patricia Chou; Haitao Zhang; Jeesun Jung; W June Ruan; Sharon M Smith; Boji Huang; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2015-09-02       Impact factor: 4.492

4.  The effects of repeated opioid administration on locomotor activity: II. Unidirectional cross-sensitization to cocaine.

Authors:  Mark A Smith; Jennifer L Greene-Naples; Jennifer N Felder; Jordan C Iordanou; Megan A Lyle; Katherine L Walker
Journal:  J Pharmacol Exp Ther       Date:  2009-04-29       Impact factor: 4.030

Review 5.  Gender differences in adolescent substance abuse.

Authors:  Angelica Kloos; Ronald A Weller; Rebecca Chan; Elizabeth B Weller
Journal:  Curr Psychiatry Rep       Date:  2009-04       Impact factor: 5.285

6.  Gender and comorbidity among individuals with opioid use disorders in the NESARC study.

Authors:  Christine E Grella; Mitchell P Karno; Umme S Warda; Noosha Niv; Alison A Moore
Journal:  Addict Behav       Date:  2009-01-30       Impact factor: 3.913

7.  Gender and prescription opioid misuse in the emergency department.

Authors:  Esther K Choo; Carole Douriez; Traci Green
Journal:  Acad Emerg Med       Date:  2014-12       Impact factor: 3.451

Review 8.  The emergence of gonadal hormone influences on dopaminergic function during puberty.

Authors:  Cynthia Kuhn; Misha Johnson; Alex Thomae; Brooke Luo; Sidney A Simon; Guiying Zhou; Q David Walker
Journal:  Horm Behav       Date:  2009-11-10       Impact factor: 3.587

9.  Co-occurring prescription opioid use problems and posttraumatic stress disorder symptom severity.

Authors:  Andrea Meier; Chantal Lambert-Harris; Mark P McGovern; Haiyi Xie; Melissa An; Bethany McLeman
Journal:  Am J Drug Alcohol Abuse       Date:  2014-05-08       Impact factor: 3.829

Review 10.  Medical and psychological risks and consequences of long-term opioid therapy in women.

Authors:  Beth D Darnall; Brett R Stacey; Roger Chou
Journal:  Pain Med       Date:  2012-08-20       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.